Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric ONcology Group randomized phase II study. - Steuber,C.P.; Krischer,J.; Holbrook,T.; Camitta,B.; Land,V.; Sexauer,C.; Mahoney,D.; Weinstein,H. (J Clin Oncol, 1996)